Navigation Links
ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results
Date:11/2/2010

e is ready to launch BROMDAY this month.  We expect to discontinue the twice-daily XIBROM (bromfenac ophthalmic solution)® 0.09% product in early 2011."

Continued Anido, "With our newest product pipeline developments, we have proven our ability to extract significant additional value from our core therapeutic compounds, bromfenac and bepotastine.  In addition to gaining approvals for BROMDAY and BEPREVE™, we initiated our REMURA™ (bromfenac ophthalmic solution for dry eye) Phase 3 clinical program, plus released the positive results of our Phase 1/2 bepotastine besilate nasal spray study.  Based upon these Phase 1/2 results, we plan to submit an Investigational New Drug (IND) Application to the FDA for bepotastine nasal spray to initiate Phase 2 clinical studies before the end of 2010.  In addition, we expect to report the results of the REMURA Phase 3 dry eye efficacy study in the middle of 2011.  Gaining approval for both product candidates would allow us to participate in significantly larger market segments than those for ISTA's current product offerings.  To complement our eye care and allergy franchises, we continue to evaluate acquiring both late-stage drug candidates to add to our pipeline and marketed products to add to our sales portfolio, assets that have the potential to deliver significant value to our stakeholders for years to come."Net Revenues

(In millions, except percentage data)Three Months Ended

September 30,

Nine Months Ended

September 30,2010

2009

Change

2010

2009

ChangeXIBROM

$29.6

$21.4

38%

$71.0

$55.1

29%BEPREVE

3.9

1.2

225%

10.6

1.2

783%ISTALOL

5.3

5.1

4%

15.0

13.0

15%VITRASE

3.2

1.4

129%

8.8

4.0

120%Product sales, net

42.0

29.1

44%

1
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. DUSA Pharmaceuticals, Inc.® to Host Third Quarter 2010 Corporate Highlights and Financial Results Conference Call
2. Access Pharmaceuticals Awarded $1.5 Million in Section 48D Grants
3. Anadys Pharmaceuticals to Report Third Quarter 2010 Financial Results
4. Alder Biopharmaceuticals Appoints Bruce Montgomery to Board of Directors
5. Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010
6. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
7. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
8. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2010 Financial Results on November 5, 2010
9. Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2010 Financial Results
10. VIDEO from thenewsmarket.com and Roche Pharmaceuticals: MabThera Approved in Europe for First Line Maintenance Treatment of Follicular Lymphoma, a Common Type of Blood Cancer
11. MAP Pharmaceuticals to Present Data Showing Low Migraine Recurrence Rates With LEVADEX™ in FREEDOM-301 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... CHENGDU, China , Dec. 23, 2014 /PRNewswire/ ... a pharmaceutical company that specializes in patented biopharmaceutical, ... active pharmaceutical ingredients (API) today announced that the ... for its Good Manufacturing Practice (GMP) certificate of ... & Drug Administration,s (CFDA). The public notice period ...
(Date:12/22/2014)... Mass. , Dec. 22, 2014 ... leading manufacturer of innovative dialysis products, announced today ... has cleared its System One™ to perform hemodialysis ... known as home nocturnal hemodialysis. NxStage,s® System One ... by the FDA for this indication. ...
(Date:12/22/2014)... , Dec. 22, 2014  ConvaTec, a privately-held medical ... has been appointed Interim Chief Executive Officer of the ... succeeds Ken Berger .  "The Board of Directors ... leading ConvaTec over the past three years," said ... Directors.  "We are confident that the company is well ...
Breaking Medicine Technology:TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2
... 2011 ,   ... SECT B) and Royal Philips Electronics,(AEX: PHI, NYSE: ... Sectra , s mammography modality,operations. The cash ... debt-free basis. The agreement,also includes an additional possible earn-out EUR ...
... 2011 OXIS International, Inc. (OTC Bulletin Board: ... it has named former Wal-Mart executive Ken Eaton to ... four members, including three independent Directors. "I ... caliber to the OXIS International Board of Directors," said ...
Cached Medicine Technology:Sectra and Philips Sign Large Mammography Modality Acquisition Deal 2Sectra and Philips Sign Large Mammography Modality Acquisition Deal 3OXIS International Names Former Wal-Mart Executive Ken Eaton to Board of Directors 2OXIS International Names Former Wal-Mart Executive Ken Eaton to Board of Directors 3
(Date:12/25/2014)... (PRWEB) December 25, 2014 When head lice ... themselves in a frenzy to get rid of it while ... families in Coral Gables now have the solution right in ... salon clinic location, Lice Troopers provides full spectrum head lice ... Coral Gable area, including Sunset, Key Biscayne, Brickell, Coconut Grove, ...
(Date:12/25/2014)... -- The risk of burns from fires and cooking ... be extra cautious, an expert says. "Between Thanksgiving ... in patients coming in with burns," said Dr. Steven ... Burn Center of Stony Brook University Hospital in New ... but if not careful, could quickly turn tragic," Sandoval ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, 2014 ... "fountain of youth" drug that can delay the effects of ... study suggests. Seniors received a significant boost to their ... signaling pathway linked to aging and immune function, researchers with ... medication, a version of the drug rapamycin, improved the seniors, ...
(Date:12/25/2014)... 2014 “ SmileStix ” was featured on ... latest and coolest mobile applications on the iOS, Android, and ... of NewsWatch, conducted the app review and shared with viewers ... stickers. , The old saying goes, “A picture says a ... that can describe a single image, because each picture holds ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 Each year ... and 2 million hospital admissions across the nation (according ... ). The CDC’s National Hospital Ambulatory Medical Care ... a survey conducted in 2010. They estimated that there ... that resulted in a primary diagnosis of broken bone ...
Breaking Medicine News(10 mins):Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 3Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 4
... -- ,Septicemia was the single most expensive condition treated ... about $15.4 billion, according to a federal government report. ... infections with bacteria such as E. coli and methicillin-resistant ... also showed that the number of hospital stays for ...
... Gardner HealthDay Reporter , FRIDAY, Oct. 7 (HealthDay ... first linked to tainted cantaloupes has risen to 21, and ... states, the U.S. Centers for Disease Control and Prevention reported ... cantaloupes in question were recalled Sept. 14, more cases might ...
... , FRIDAY, Oct. 7 (HealthDay News) -- A community-based ... smoking, drinking, violence and other bad behavior, according to ... helps communities choose programs that have been shown to ... was developed by University of Washington researchers, who conducted ...
... , FRIDAY, Oct. 7 (HealthDay News) -- Exposing children ... risky to their well-being as long as sedation and ... The study finds that MRIs, when used without additional ... or psychological harm to healthy children than routine activities ...
... of novel imaging agents could make it possible to ... deadly. , The compounds, derived from inhibitors of the ... (PET) imaging, may have broad applications for cancer detection, ... new imaging agents in a paper featured on the ...
... FRIDAY, Oct. 7 (HealthDay News) -- Boys with autism tend ... infants seen in their head size, height and weight, a ... new clues about the underlying mechanisms of autism. A larger ... brain. Boys with brain and body "overgrowth" tend ...
Cached Medicine News:Health News:21 Deaths From Cantaloupe-Linked Listeria Outbreak: CDC 2Health News:21 Deaths From Cantaloupe-Linked Listeria Outbreak: CDC 3Health News:Community-Wide Effort May Help Tame Troubled Teens 2Health News:Simple MRIs Safe for Children, Study Says 2Health News:Simple MRIs Safe for Children, Study Says 3Health News:Imaging agents offer new view of inflammation, cancer 2Health News:Boys With Autism May Grow Faster as Babies 2Health News:Boys With Autism May Grow Faster as Babies 3
The balloon catheter is designed to pass over a previously placed .015 inch diameter wire guide included. Supplied sterile in peel-open packages. Intended for one-time use....
The removable inflation/injection adapter allows the cystoscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use....
Radiopaque markers indicate the proximal and distal ends of the balloon. Supplied sterile in peel-open packages. Intended for one-time use....
Radiopaque markers are placed at the proximal and distal ends of the balloon. A special pin vise handle is included to stabilize the wire guide during introduction. Supplied sterile in peel-open pack...
Medicine Products: